Unspecified interleukin-6 receptor inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified interleukin-6 receptor inhibitor, covering 2025-07-28 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis [Phase 3]